YCM
APGN

Yakira Capital Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Yakira Capital Management’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-171,400
Closed -$1.74M – 458
2022
Q2 		$1.74M Buy
+171,400
New +$1.73M 0.27% 126

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Yakira Capital Management's APGN Position: Q3 2022 in Review

Yakira Capital Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 171,400 shares — an estimated $1.74M sold.

Yakira Capital Management first reported a position in APGN in Q2 2022 and held it in 1 quarter. The position peaked at $1.74M in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Yakira Capital Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Yakira Capital Management sold 171,400 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $1.74M.
  • Yakira Capital Management first reported a position in Apexigen, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Yakira Capital Management's Apexigen, Inc. Common Stock position peaked at $1.74M in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Yakira Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.